Trial Shows New Imaging System May Cut X-Ray Exposure for Liver Cancer Patients - 12/1/14
Johns Hopkins researchers report that their test of an interventional X-ray guidance device approved by the U.S. Food and Drug Administration in 2013 has the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy (IAT) for liver cancer.
Source: Johns Hopkins Medicine News - Category: Research Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Liver | Research | Urology & Nephrology